MedTrace Logo

Cancer Therapy-related Cardiac Dysfunction Occuring in Children Treated by Anticancer Drugs for Malignancies

NCT05602103 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2024-05-29

No results posted yet for this study

Summary

Little is known about cancer therapy-related cardiac dysfunction occuring in children treated by anticancer drugs for malignancies. Here the investigators use VigiBase (http://www.vigiaccess.org/), the World Health Organization (WHO) database of individual safety case reports, to identify and describe cases of cancer therapy-related cardiac dysfunction associated with anticancer drugs.

Conditions

Interventions

DRUG

use of anticancer drugs in monotherapy or in combination therapy

Cases of cancer therapy-related cardiac dysfunction associated with anticancer drugs will be identify and describe

Sponsors & Collaborators

  • University Hospital, Caen

    lead OTHER

Principal Investigators

  • Joachim Alexandre, MD, PhD · Caen Normandy University Hospital, France

Eligibility

Min Age
0 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-05
Primary Completion
2025-01-01
Completion
2025-01-06
FDA Drug
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05602103 on ClinicalTrials.gov